Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| OptimizeRx CorpOPRX · Entity 213 | Director | June 01, 2017 | June 02, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
OptimizeRx Corp
Report date June 01, 2017 · Filed June 02, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 2,090,750 |
Reported balance
After 2017-06-01 transaction · row 1
1 source rowRow 1 · 2017-06-01 · Disposition to issuer · Disposed 500,000 · Balance 2,090,750 F1: The shares were repurchased by the Company pursuant to an agreement dated May 11, 2017, which is attached to the Company's Form 8-K and filed with the SEC on May 17, 2017. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were repurchased by the Company pursuant to an agreement dated May 11, 2017, which is attached to the Company's Form 8-K and filed with the SEC on May 17, 2017.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 01, 2017 Filed Jun 2, 2017 17:18 UTC | OptimizeRx Corp OPRX · Entity 213 | Disposition to issuerCommon Stock | 500,000 | $0.78 | $390,000.00 |
DisclosureSEC source: 0001213900-17-006118 · f4060117harrell_optimizerx.xml · nonDerivative · entry 1 Harrell David · CIK 0001466061 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,090,750 F1 · shares: The shares were repurchased by the Company pursuant to an agreement dated May 11, 2017, which is attached to the Company's Form 8-K and filed with the SEC on May 17, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.